(Q39668181)

13 September 2017

title

A neurocomputational model for prostate carcinoma detection (English)

1 reference

13 September 2017

1 reference

4

Alan W Partin

1 reference

13 September 2017

Pankaj Kalra

1

1 reference

13 September 2017

Joanna Togami

2

1 reference

13 September 2017

Gaurav Bansal B S

3

1 reference

13 September 2017

Michael K Brawer

5

1 reference

13 September 2017

Richard J Babaian

6

1 reference

13 September 2017

Lawrence S Ross

7

1 reference

13 September 2017

Craig S Niederberger

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

13 September 2017

1 reference

13 September 2017

volume

98

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

1849-1854

1 reference

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Informed consent for prostate-specific antigen screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Prostate-specific antigen as a screening test for prostate cancer. The United States experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Family history and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Detection of prostate cancer in males with prostatism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

The Large-Sample Distribution of the Likelihood Ratio for Testing Composite Hypotheses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Familial patterns of prostate cancer: a case-control analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Mendelian inheritance of familial prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Genetic aspects of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Disease-specific survival following routine prostate cancer screening by digital rectal examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Interexaminer variability of digital rectal examination in detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Measurement of complexed PSA improves specificity for early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11748

7 January 2021

Identifiers

DOI

10.1002/CNCR.11748

1 reference

13 September 2017

1 reference